Brainomix, a leader in artificial intelligence (AI) imaging solutions, has announced a partnership with the German pharmaceutical giant Boehringer Ingelheim. This collaboration aims to enhance the care of patients suffering from fibrosing lung disease in the United States through the innovative application of AI imaging analysis. The partnership will focus on utilizing Brainomix’s FDA-cleared e-Lung […]
Octagos Health, a trailblazer in AI-driven cardiac device monitoring, has successfully raised over $43 million in a Series B funding round. The investment was spearheaded by Morgan Stanley Expansion Capital and saw significant contributions from Mucker Capital along with other strategic investors. This infusion of capital is set to accelerate Octagos Health’s innovative mission to […]
Roche (SIX: RO, ROG; OTCQX: RHHBY), a global leader in pharmaceuticals and diagnostics, announced a significant advancement in eye care with the U.S. Food and Drug Administration’s (FDA) approval of the Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS). This new formulation is approved for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD), […]
In a significant development for the treatment of drug-resistant tuberculosis (TB), Johnson & Johnson has announced that SIRTURO (bedaquiline) has received full approval from the U.S. Food and Drug Administration (FDA) and the European Commission (EC). This approval marks a pivotal milestone in the fight against pulmonary TB that is resistant to standard treatments like […]
The U.S. Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt), an Alzheimer’s treatment developed by Eli Lilly and Company (NYSE: LLY). This treatment, specifically designed for adults with early symptomatic Alzheimer’s disease, includes those with mild cognitive impairment (MCI) and the mild dementia stage of Alzheimer’s, with confirmed amyloid pathology. Priced at $350 million […]
Amsino Medical Group, a prominent global provider of medical consumable devices, has successfully concluded a significant equity investment from Novo Tellus, a leading investment firm specializing in the global supply chain. This strategic partnership, which officially closed in June 2024, marks a renewed collaboration between the two entities, following their previous successful alliance from 2011 […]
Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for the discovery of new antimicrobials, aiming to tackle the critical issue of antimicrobial resistance (AMR). This initiative marks a significant advancement in the pharmaceutical industry’s efforts against one of the most daunting health challenges today. Antimicrobial resistance […]
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Promaxo Inc., a leading developer of portable low-field MRI systems and minimally invasive robotics based in the U.S. This strategic partnership aims to advance healthcare innovation, particularly in the field of prostate cancer diagnosis and treatment. Promaxo’s groundbreaking […]
Co-Diagnostics, Inc. (Nasdaq: CODX), a pioneering molecular diagnostics company, has reached a pivotal milestone by completing its first U.S. Food and Drug Administration (FDA) application for 510(k) clearance. This application pertains to both the Co-Dx PCR Pro instrument and the Co-Dx PCR COVID-19 Test intended for over-the-counter (OTC) use. The submission was made through the […]
Roche and Hitachi High-Tech have announced a significant extension of their partnership, solidifying at least another decade of collaboration in the field of in-vitro diagnostics. This renewal builds on a long-standing relationship that has consistently delivered groundbreaking medical technologies and innovations. Decades of Collaborative Success in Diagnostics Since their initial collaboration in 1978, Roche and […]
